| TCRT |
Alaunos Therapeutics, Inc. |
Postma Robert W |
|
2026-01-12 |
A - A |
5,622 |
2.89 |
16,247.58 |
43,872 |
| TCRT |
Alaunos Therapeutics, Inc. |
Jerman Michael Allen |
|
2026-01-12 |
A - A |
5,406 |
2.89 |
15,623.34 |
9,589 |
| SYM |
Symbotic Inc. |
Boyd William M III |
Officer
|
2026-01-12 |
A - A |
10,723 |
0.00 |
0.00 |
29,922 |
| CHGG |
CHEGG, INC |
Longo David |
Officer
|
2026-01-12 |
F - D |
1,815 |
0.92 |
1,669.80 |
2,169,385 |
| CHGG |
CHEGG, INC |
Longo David |
Officer
|
2026-01-12 |
F - D |
262,923 |
0.92 |
241,889.16 |
1,906,462 |
| NYC |
American Strategic Investment Co. |
New York City Advisors, LLC |
10% Owner
|
2026-01-12 |
P - A |
1,224 |
9.25 |
11,322.00 |
1,056,936 |
| ASGN |
ASGN Inc |
HOLMAN JONATHAN S |
Director
|
2026-01-12 |
J - D |
1,683 |
50.80 |
85,496.40 |
13,893 |
| ABOS |
Acumen Pharmaceuticals, Inc. |
OConnell Daniel Joseph |
Director
Officer
|
2026-01-12 |
S - D |
5,388 |
1.73 |
9,306.69 |
593,510 |
| ABOS |
Acumen Pharmaceuticals, Inc. |
Meisner Derek M |
Officer
|
2026-01-12 |
S - D |
8,548 |
1.71 |
14,658.11 |
83,800 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
2,270,879 |
0.00 |
0.00 |
2,270,879 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
202,862 |
0.00 |
0.00 |
202,862 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
128,506 |
0.00 |
0.00 |
128,506 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
P - A |
2,077,779 |
18.00 |
37,400,022.00 |
4,348,658 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
P - A |
144,443 |
18.00 |
2,599,974.00 |
347,305 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
9,913,810 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
997,299 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
488,891 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
2,397,500 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
102,500 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
965,190 |
0.00 |
0.00 |
965,190 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
86,222 |
0.00 |
0.00 |
86,222 |
| AKTS |
Aktis Oncology, Inc. |
Kim Helen Susan |
|
2026-01-12 |
C - A |
4,859,370 |
0.00 |
0.00 |
4,859,370 |
| AKTS |
Aktis Oncology, Inc. |
Kim Helen Susan |
|
2026-01-12 |
P - A |
812,455 |
18.00 |
14,624,190.00 |
5,671,825 |
| AKTS |
Aktis Oncology, Inc. |
Kim Helen Susan |
|
2026-01-12 |
C - A |
134,842 |
0.00 |
0.00 |
134,842 |
| AKTS |
Aktis Oncology, Inc. |
Kim Helen Susan |
|
2026-01-12 |
P - A |
22,545 |
18.00 |
405,810.00 |
157,387 |